Study of CG0070 Given in Combination With Pembrolizumab, in Non-Muscle Invasive Bladder Cancer, Unresponsive to Bacillus Calmette-Guerin

New York University, New York

SUNY Upstate Medical University, Syracuse

Keystone Urology Specialists, Lancaster

Fox Chase Cancer Center, Philadelphia

Chesapeake Urology, Hanover

Johns Hopkins Medical Institution, Baltimore

Moffitt Cancer Center, Tampa

Northwestern University, Tampa

Ohio State University, Columbus

Pusan National University Yangsan Hospital, Yangsan

Chonnam National University Hwasun Hospital, Hwasun

University of California - San Diego, La Jolla

University of California - Irvine, Orange

Spokane Urology, Spokane

Mayo Clinic - Rochester, Rochester

Korea University Anam Hospital, Seoul

Seoul National University Hospital, Seoul

The Catholic University of Korea Seoul St. Mary's Hospital, Seoul

Severance Hospital, Sinchŏn-dong